Health Condition 1: D508- Other iron deficiency anemias
Conditions
Interventions
Intervention1: INTRA VENOUS FERRIC CARBOXY MALTOSE: IV Ferric carboxy maltose(FCM) is a third generation parenteral iron preparation designed to overcome the limitations of existing parenteral iron pr
Sponsors
Subhashree Kar
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age 18 years and above of either sex. 2.All diagnosed patients of severe IDA, attending Clinical Haematology & Medicine Department of SCB Medical College and Hospital, Cuttack. 3.TSAT Levels less than 30% 4.He/She must be willing to comply to study protocol till the end of the trial. 5.He/She is willing to give written informed consent at the baseline visit. 6.All patients will be provided with patient information sheet regarding all pros and cons of the study at the baseline visit.
Exclusion criteria
Exclusion criteria: 1.Age 2.Pregnant and Lactating women 3.Anemia due to any other cause other than IDA 4.Patients with known history of hypersensitivity to iv Iron injection 5.Patients with iron treatment or blood transfusion within 4weeks prior to treatment 6.Patients with recent history of treatment with Erythropoetin.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Efficacy of FCM in comparison to iv Iron sucrose in treating IDA using laboratory assays between two groups A and B. 2.% Change in Hb, Serum Ferritin levels and Transferrin saturation levels 3.Assessing SAFETY PROFILE of FCM in comparision to iv iron sucrose.Timepoint: 1. At baseline visit, 2weeks, 4weeks and 12weeks interval. | — |
Secondary
| Measure | Time frame |
|---|---|
| quality of life assesment using SF36 questionnaireTimepoint: At 4 weeks and 12 weeks interval from the start of the treatment | — |
Countries
India
Contacts
Public ContactTrupti Rekha Swain
SCB Medical College and Hospital, Cuttack
Outcome results
None listed